Vertex Pharmaceuticals (VRTX) Income from Non-Controlling Interests (2011 - 2018)
Vertex Pharmaceuticals (VRTX) posted Income from Non-Controlling Interests of -$25.43 million for Q4 2018, compared with $1.5 million a year earlier.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Income from Non-Controlling Interests (2011 - 2018) Analysis & Trends
For FY2018, Vertex Pharmaceuticals' Income from Non-Controlling Interests came in at -$9.79 million.
- In prior years, Vertex Pharmaceuticals' Income from Non-Controlling Interests was -$171.85 million in FY2017, $28.02 million in FY2016 and -$31.85 million in FY2015.
- The Q4 2018 figure stands as the lowest quarterly Income from Non-Controlling Interests since Q3 2017.
- According to Business Quant data, Income from Non-Controlling Interests for the three prior quarters was -$290,000 (Q3 2018), -$1.11 million (Q2 2018) and $17.04 million (Q1 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | - |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 3.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -2.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -7.00 Mn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 10.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Bristol Myers Squibb | 130.49 Bn | 81.76 Bn | 9.25 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | -25.43 Mn |
| Sep 30, 2018 | -290,000.00 |
| Jun 30, 2018 | -1.11 Mn |
| Mar 31, 2018 | 17.04 Mn |
| Dec 31, 2017 | 1.50 Mn |
| Sep 30, 2017 | -188.32 Mn |
| Jun 30, 2017 | 13.17 Mn |
| Mar 31, 2017 | 1.79 Mn |
| Dec 31, 2016 | -5.19 Mn |
| Sep 30, 2016 | -696,000.00 |
| Jun 30, 2016 | 28.37 Mn |
| Mar 31, 2016 | 5.53 Mn |
| Dec 31, 2015 | -938,000.00 |
| Sep 30, 2015 | 1.33 Mn |
| Jun 30, 2015 | -32.14 Mn |
| Mar 31, 2015 | -98,000.00 |
| Dec 31, 2013 | -228.83 Mn |
| Sep 30, 2013 | -4.53 Mn |
| Jun 30, 2013 | -4.55 Mn |
| Mar 31, 2013 | -4.61 Mn |
API Access
Vertex Pharmaceuticals Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();